GGrantIndex
← Search

Human Tissue Aquisition and Pathology Shared Resource

$301,073P30FY2014CANIH

Vanderbilt University, Nashville TN

Investigators

Linked publications, trials & patents

Trial NCT07016399Trial NCT06593106Trial NCT05501665Trial NCT05361720Trial NCT04765072Trial NCT02702310Trial NCT02685631Trial NCT02677883Trial NCT02676752Trial NCT02672475Trial NCT02658487Trial NCT02600533Trial NCT02489422Trial NCT02480114Trial NCT02457910Trial NCT02448225Trial NCT02440737Trial NCT02374931Trial NCT02359851Trial NCT02324881Trial NCT02296112Trial NCT02269111Trial NCT02240381Trial NCT02236546Trial NCT02170272Trial NCT02151539Trial NCT02148406Trial NCT01996527Trial NCT01928160Trial NCT01901367Trial NCT01660971Trial NCT01230515Trial NCT01198535Trial NCT01141218Trial NCT01098669Trial NCT01098643Trial NCT01096407Trial NCT01096394Trial NCT01096381Trial NCT01077440Trial NCT01031446Trial NCT01013506Trial NCT01009931Trial NCT01007422Trial NCT00993694Trial NCT00993135Trial NCT00987766Trial NCT00984542Trial NCT00984490Trial NCT00983268Trial NCT00957736Trial NCT00949052Trial NCT00930930Trial NCT00900406Trial NCT00900003Trial NCT00899769Trial NCT00899626Trial NCT00899457Trial NCT00899301Trial NCT00899028Trial NCT00898742Trial NCT00898638Trial NCT00898430Trial NCT00898313Trial NCT00897988Trial NCT00897832Trial NCT00897793Trial NCT00897650Trial NCT00897468Trial NCT00897403Trial NCT00897117Trial NCT00896948Trial NCT00896675Trial NCT00892801Trial NCT00875238Trial NCT00840814Trial NCT00837876Trial NCT00835679Trial NCT00801346Trial NCT00765245Trial NCT00755040Trial NCT00675636Trial NCT00670644Trial NCT00670605Trial NCT00670046Trial NCT00666211Trial NCT00656604Trial NCT00653250Trial NCT00651976Trial NCT00651716Trial NCT00647218Trial NCT00626873Trial NCT00625417Trial NCT00625066Trial NCT00616590Trial NCT00601991Trial NCT00573404Trial NCT00550537Trial NCT00544648Trial NCT00533884

Abstract

The goal of the Human Tissue Acquisition and Pathology Shared Resource (HTAP) is to provide human tissue samples and histology services to support translafional and preclinical aspects of cancer research. This resource has been in operation since 1993; at the last competitive renewal, this shared resource received an Outstanding rating. HTAP provides researchers with access to a wide variety of human specimens and fissues. HTAP's objectives are to collect, process, bank, and distribute remnant human tissues (both normal and neoplastic) from routine surgical resections and autopsies for use by peer-reviewed and funded Vanderbilt-lngram Cancer Center (VICC) investigators in basic, clinical, and translafional research studies. This includes providing the highest quality, well-characterized fresh, frozen, and fixed tissues suitable for a wide range of molecular, biochemical, and tissue analyses. HTAP will also assist with the collection and banking of biopsy material for specific cancer-related clinical trials and other projects and will perform quality control to ensure that the relevant tissue is supplied to the researcher, and that fissues are suitable for the planned research (e.g., not necrofic or involved by unsuspected disease processes). HTAP is well situated in regards to space and equipment. Services highly utilized by VICC investigators and only provided by HTAP include laser capture microscopy, tissue array construction and image analysis. This shared resource is of critical importance for the translational work of VICC invesfigators. Mary Zutter, M.D., Professor of Pathology and Cancer Biology and Ingram Professor of Cancer Research, became scientific director in May 2009. Dr. Zutter directs a research laboratory that focuses on the role of cell adhesion molecules in host-tumor interactions. She has been funded continuously by the NIH for the past 17 years and is currently supported by three R01 grants from the NCI. In addition, she is board certified in Anatomic and Clinical Pathology and directs the Division of Hematopathology. She is assisted by a staff with decades of experience and by the Informafics Shared Resource, under the direction of Dan Masys, M.D.

View original record on NIH RePORTER →